[Video] | The DMT And Ayahuasca Experience As Described by Joe Rogan, Graham Hancock And Terence McKenna

Dimethyltryptamine (DMT) is the psychoactive compound which is the active ingredient in the shamanistic brew called Ayahuasca. Used by Shamans, seers and so called “psychonauts” to access higher states of consciousness, this transformative experience has been changing lives behind the scenes for thousands of years. Bridging the mental, spiritual and physical worlds, these controversial chemicals open up those drawn to the experience to a novel experience of reality which incorporates a sense of non-locality of consciousness.

The narration used in this lecture were taken from various podcasts including
‘The Joe Rogan Experience’, ‘London Real’ and ‘The Psychedelic Salon’.

Sacred Medicine Profane Laws: Can Entheogens be Used As An Adjunct Treatment for Individuals Experiencing Addiction

 

Sacred Medicine Profane Laws: Can Entheogens be Used As An Adjunct Treatment for Individuals Experiencing Addiction

Farrah Sharpe

Introduction

Addiction is a complex dis-ease commonly categorized as self-medication or chronic self-abuse. Some even claim it to be a slow form of suicide. It is safe to say that drug addiction is an evolving complex disorder that has many levels of dis-ease eventually taking over every aspect of an individual’s life. This is an unnecessary occurrence. If a human soul is crying out for help by becoming addicted to substances that allow him to feel better, as a society we should not label these individuals addicts but instead tend to the needs of their soul.  According to the 2000 National Survey of Substance Abuse Treatment Services (NSSATS), currently over 1 million people in the United States are receiving treatment for drug or alcohol addiction. Substance abuse programs have become a multi-billion dollar industry in America, and its programs are designed and funded by state, government and privately sponsored companies.

Addicts speak of an internal self-defeating dialog that compels them to fall prey to their addiction. Their goal in life then becomes to fill the need for something more, something to ingest, shoot up, inhale or smoke. The United States government has implemented treatment programs to assist individuals who have selected the dis-ease of addiction. The United States Department of Health and Human Services, the Substance Abuse and Mental Health Services Administration (SAMHSA) and the Office of Applied Studies have come together to collect information from all treatment facilities in the United States, both public and private, that provide substance abuse treatment. Neither of these institutions have explored the internal dialog that occurs when an individual is experiencing sacred entheogenic medicines. There is research to suggest that sacred entheogenic medicines have the ability to heal a multitude of human illnesses.

Problem Being Addressed

The ideals of SAMHSA are noble, but treatment progress is at a standstill and the numbers of those suffering from addiction are growing. New research suggests that the incorporating entheogens into the healing process may be used as an adjunct treatment for individuals experiencing addiction to various substances. Incorporating entheogens or “sacred” plant medicines and psychospiritual healing practices into substance abuse programs have had great success in preliminary trials in other countries, yet they are still not being used in treatment facilities in the US.  As of today, psychospiritual medicines or sacred medicines found in plants around the world are illegal in the United States. In February 2006, the United States Supreme Court ruled that religious freedom may trump U.S. drug laws with respect to the ceremonial use of DMT MEO-5, Bulfo Alvarus Toad and or Ayahuasca, a tea indigenous to the Amazon and long revered by its peoples (Hollman, 2006). This ruling would suggest that the psychological community would find a way to incorporate the use of sacred entheogenic medicines into therapy work but they are not. Why is there a blackout of information surrounding this subject?

Research questions. This inquiry seeks to answer these questions:

  1. Can entheogens, primarily DMT MEO-5 and Ayahuasca, be used as a tool to facilitate the healing of addiction and other psychological issues?
  2. How long will this process take?
  3. What are the long-term effects of DMT MEO-5 and Ayahuasca?
  4. Does theDMT MEO-5 and Ayahuasca solve a client’s mental and emotional dilemmas, including those that caused the addictive behavior initially?
  5. If proper evidence is provided will the United States Government release its ban on entheogens and other plant medicines?

Identification of Independent and Dependent Variables

In the United States, more than 14,500 specialized drug treatment facilities provide counseling, behavioral therapy, medication, case management, and other types of services to persons with substance use disorders. (National Institute on Drug Abuse, 2012) SAMHSA collects this multipurpose data to access the nature and extent of services provided and in forecasting treatment resource requirements, update SAMHSA’s Inventory of Substance Abuse Treatment Services (I-SATS), analyze general treatment services trends, and generate the National Directory of Drug and Alcohol Abuse Treatment Programs and its online equivalent, the Substance Abuse Treatment Facility Locator. (SAMHSA, 2008)

The 2000 National Survey of Substance Abuse Treatment Services (N-SSATS) conducted a 6 month survey collecting data on topics including:

Facility operation, services offered (assessment, testing, transitional, ancillary, and pharmacotherapies), detoxification, primary focus (substance abuse, mental health, both, general health, and other), Opioid Treatment Programs and medications dispensed/prescribed, counseling and therapeutic approaches, standard operating procedures, special programs/groups offered, languages in which treatment is provided, type of treatment provided (hospital inpatient, residential, outpatient), number of clients (by service, total, and under age 18), number of beds, types of payment accepted, sliding fee scale, and facility accreditation and licensure/certification. (SAMHSA, 2008)

This research is necessary in order to build a workable framework in assessing the successes, failures, progress and to track statistics in substance abuse treatment programs. The inclusion of treatment plans that include sacred medicines have the opportunity to increase the maximum potential of a client’s healing process. Plants that grow in the Amazon Rainforest or originate from animals have been unfairly labeled drugs in the United States and have not had received the proper research needed to understand this complex soul medicine. In response, spiritual seekers and psychologists alike science is being forced more than ever before, to define, defend or redefine the social boundaries between the sacred and the profane in the face of modernization and globalization of sacred medicines ” (Tupper, 2008) Should a person have access to choose for herself how far she wants to heal and explore her own mind? Why are there laws against entheogens?

Key Findings

The Department of Health and Human Services (DHHS) surveyed substance abuse treatment facilities and discovered that outpatient, residential (nonhospital), and hospital inpatient services changed very little from 2004 to 2008 in terms of the proportion of facilities size, type of care provided and the proportion of clients in treatment in each type of facility. (Department of Health and Human Services, 2009)  This study suggests that sustaining the existing condition of substance abuse facilities is the goal and not essentially seeking a cure to the cause of addiction. As an example, in the case of heroin addiction, the system is currently designed to offer heroin addicts methadone as a substation. Methadone is equally as addictive and damaging to the human body, and the primary cause for the addiction is further buried in the subconscious mind of the individual. The DHHS study listed the proportion of clients receiving methadone ranged from 22% to 24% and clients in treatment for both drug and alcohol abuse made up 45% to 46% of all clients. (Department of Health and Human Services, 2009)

The growing interest in healing through entheogens and sacred plant medicines such as Ayahuasca, Psilocybin Mushrooms, DMT MEO-5 and Marijuana by modern American citizens poses significant theoretical challenge regarding offering adequate treatments, drugs and drug policies. When treating addiction, traditional counseling coupled up with current pharmaceutical medication is limited in its ability to heal and on occasion the prescribed medications prove to be addictive and or harmful to the human body. This research paper suggests that by modernizing substance abuse programs to include Ayahuasca and other plant medicines to be used in individual and group sessions, in a controlled environment with daily meditation will increase the success rates of patients addicted to various substances and also heal a number of psychological issues that plague American society.

Conclusion

The history of entheogens and plant medicine research is rich in its ability to heal as a medicine, provide ceremony for the refreshing the soul, and a powerful plant teacher that transports one to the depths of their being for learning. Social and cultural constructs tend to deny that inner peace and personal fulfillment are a major aspect of being human. This self and soul denial could be the primary  reason addiction is so common in American society in the first place. Ethnogens offers a deeply spiritual experience that allows a person to experience their own personal demons and evolve from them. This phenomenon demands reconsideration of some of the metaphysical and sociological assumptions of current drug policies. (Tupper, 2008) At present several psychological studies on healing with entheogens and their ability to help the human mind and soul to realign itself have opened the door to possible use of entheogens therapy for healing addiction and other psychological issues in future.

References

Hollman, K. H. (2006, March/April). Quiet case may have far-reaching impact. Liberty Magazine [Retrieved May 24, 2006 from: http://www.libertymagazine.org/article/articleview/562/1/89/

Tupper, K. (2008). The Globalization of Ayahuasca: Harm Reduction or Benefit Maximization? International Journal of Drug Policy, Volume 19(Issue 4), 297-303.

DuPont, R. L. (1979). Marihuana: A review of the issues regarding decriminalization and legalization. In G. M. Beschner &.A. S. Friedman (Eds.), Youth drug abuse: Problems, issues, and treatment (pp. 279-284). Lexington, MA: Lexington Books.

Erowid. (2011). Ayahuasca: Legal status. The vaults ofErowid. Retrieved from http://www.erowid.org/chemicals/ayahuasca/ayahuasca_law.shtml

Osborn, S. N. (2012). A phenomenological study of ayahuasca and its effect on anxiety (Order No. 3537480). Available from ProQuest Dissertations & Theses Full Text. (1321627504). Retrieved from http://ezproxy.snhu.edu/login?url=http://search.proquest.com/docview/1321627504?accountid=3783

Inciardi, J. A. (1999). The Drug Legalization Debate. Thousand Oaks: Sage Publications.

Schmoke, K. L. (1989). Foreword. American Behavioral Scientist? 32(3), 231-232

Marvin-Humann, K. (2008). The relationship between motivation, maslow’s hierarchy of needs, time, and craving levels in the mandated substance abuse treatment population (Order No. 3335429). Available from ProQuest Central; ProQuest Dissertations & Theses Full Text. (304835158). Retrieved from http://ezproxy.snhu.edu/login?url=http://search.proquest.com/docview/304835158?accountid=3783

Osborn, S. N. (2012). A phenomenological study of ayahuasca and its effect on anxiety (Order No. 3537480). Available from ProQuest Dissertations & Theses Full Text. (1321627504). Retrieved from http://ezproxy.snhu.edu/login?url=http://search.proquest.com/docview/1321627504?accountid=3783

National Institute on Drug Abuse. (2012, December 1). Principles of Drug Addiction Treatment: A Research-Based Guide (Third Edition). Retrieved November 23, 2014, from http://www.drugabuse.gov/publications/principles-drug-addiction-treatment-research-based-guide-third-edition/drug-addiction-treatment-in-united-states

United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies. National Survey of Substance Abuse Treatment Services (N-SSATS), 2000- 2008. ICPSR03436-v5. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 2014-04-25. http://doi.org/10.3886/ICPSR03436.v5

Sacred Medicine Profane Laws Introduction and Literature Review

Farrah Sharpe

Southern New Hampshire University

Sacred Medicine Profane Laws Literature Review

Introduction

When treating addiction, traditional counseling coupled with current pharmaceutical medication is limited in its ability to heal and on occasion the prescribed medications prove to be more addictive and or harmful to the human body. This research paper suggests that by modernizing substance abuse programs to include Ayahuasca and other plant medicines to be used in individual and group sessions, in a controlled environment with daily meditation will increase the success rates of patients addicted to various substances and also heal a number of psychological issues that plague American society.

Problem Statement

The results of the 2008 National Survey of Substance Abuse Treatment Services (NSSATS) show that there are over one million 1 million people who are addicted to drugs and alcohol in the United States.  (National Survey of Substance Abuse Treatment Services, 2008) The NSSATS provides an ample amount of relevant information with its primary focus on:

  • Multipurpose data that is used to assist the Substance Abuse and Mental Health Services Administration (SAMHSA)
  • State and local governments in assessing the nature and extent of services provided
  • Forecasting treatment resource requirements
  • Updating SAMHSA’s Inventory of Behavioral Health Services (I-BHS)
  • Analyzing general treatment services trends
  • Generating the online Behavioral Health Treatment Facility Locator
  • Generating the National Directory of Drug and Alcohol Abuse Treatment Programs (SAMHDA, 2012)

This data is complete and comprehensive in its data set yet the survey fails to include in its research surveys the success rates of each facility, the treatment programs they provide and the success rates of each treatment program.

The research study and data provided by NSSATS is geared to studying data which relates to a materialistic view of substance abuse and discounts the varying levels of needs that each person has as Maslow’s Hierarchy of Needs points out. According to one widely accepted theory of motivation there are six motivational stages for those attempting to stop using drugs. These stages are precontemplation, contemplation, preparation, action, maintenance, and relapse. (Marvin-Humann, 2008) The concern here is that all available sources of treatment are not being surveyed, studied or acknowledge as a viable resource for curing dis-ease and addiction. The human being and the varying levels of consciousness the mind is able to experience presents a finer distinction between the physical and mental spheres that the surveys and tests of today are equipped for. Social and cultural constructs tend to deny this phenomenon but it demands reconsideration.

Literature Review

For Treatment or For Profit?

Another important survey to mention here is National Survey of Substance Abuse Treatment Services (N-SSATS) which as mentioned above gathers information from all treatment facilities in the United States. As stated in the report several facilities offer Methadone/LAAM as a treatment and is dispensed by 9 percent of all facilities. The study went on to say that facilities most likely to dispense methadone were private for profit facilities and federal government facilities, particularly those operated by the Veterans Administration (VA). State government facilities also were more likely than nongovernment facilities to dispense methadone. (Alcoholism & Drug Abuse Weekly, 2002) A substance like methadone is preferable to heroine but in actuality it is an unnatural substance that is harmful to the human being. Methadone may give hereon addicts an alternative to shooting up or snorting the drug but in alignment with the APA ideals of do no harm and in keeping  transparency it exchanges one drug for another alleviating physical symptoms of withdrawal. (Galloway, 2007)

Little Change

As in the case with data collected from the Department of Health and Human Services (DHHS) in December 2009, as they surveyed Substance Abuse Treatment Facilities, studies show that outpatient, residential (nonhospital), and hospital inpatient services changed very little from 2004 to 2008 in terms of the proportion of facilities offering each type of care or the proportion of clients in treatment in each type of care. This study illustrates that there has little change in the success rates of current treatment plans.  The DHHS study lists a proportion of clients receiving methadone ranged from 22% to 24% and clients in treatment for both drug and alcohol abuse made up 45% to 46% of all clients. (Department of Health and Human Services, December 2009) Methadone and similar treatments are very addictive and tend to band aid the psychological causes of heroin addiction. These numbers are high considering the untapped non addictive medicines that are available but are labeled illegal by the United States.  This halt in studying plant medicines found in indigenous cultures also halts the progress of treating people afflicted by substance abuse.

 

Malevolent Agents and Pathogens

There are two dominant metaphors that underlie current drug policies “malevolent agents” and “pathogens” which are 2 words that are unsupportive in framing policies with respect to entheogenic substance use. Ayahuasca has been labeled a pathogen and its long tradition of use as a ritual, medicine, and plant teacher have been discounted by the Food and Drug Administration (FDA). The FDA maintains strict guidelines for approval for products that are appropriate and fit for human consumption.  Kenneth Tupper from the Department of Educational Studies at the University of British Columbia states the FDA has approved cigarettes and alcohol and these are both items that can be purchased at any corner store and both of these substances are known for their addictive qualities and long term use of either cigarettes or alcohol result in death. (Tupper, 2008)  The sale of products that produce death as an outcome is sketchy and one must consider the underlying objective of the FDA by its legalization and sale of cigarettes and alcohol and ban of plant medicines that grow in nature.

Decriminalization of Plant Medicines

Alcohol can be noted throughout history as a human cultural universal as archaeologists have found evidence of it through the ages. Other research shows that other cultures enjoy the chewing of coca and other psychoactive plants, including the opium poppy plant which grows abundantly in several regions of the world. These and other substances are used in spiritual and religious rituals by native indigenous cultures since prehistoric times. Schmoke’s stated that for generations the United States had been pursuing policies of prosecution and repression that resulted in little more than overcrowded courts and prisons, increased profits for drug traffickers, and higher rates of addiction (Schmoke, 1989). In a February 4, 1979 speech, Dr. Robert DuPont (the previous director of the National Institute on Drug Abuse, or NIDA) stated, “There are sound reasons for decriminalizing [marijuana]” (DuPont, 1979). DuPont suggests that tobacco and alcohol are psychotropic drugs that are already on the market, legal and widely distributed by legitimate businesses, and it is senseless to criminalize a substance (marijuana) that is apparently much less harmful than those two already available drugs. He also makes a point to suggest that if legalization had negative consequences, it is the right of the law makers to reverse the decision.

Bans on plant medicines like marijuana and Ayahuasca regardless of their health benefits suggest bias based on profit and the criminalization of these and other plant medicines by the FDA unwarranted. Could the anti-drug war propagation of recent history be inaccurate and deprecatory representations of plant medicines and their benefits be misconstrued intentionally?  As any scientist would suggest a proactive approach to include   research trials assessing the risks and benefits of plant medicines would provide new and new informed research which can then be presented for review.

Brazil at Forefront of Research

In the United States, Dimethyltryptamine (DMT) an ingredient found in Ayahuasca is classified as a Schedule I drug under the Controlled Substances Act of 1970 (Erowid, 2011). In 1971 a United Nations Convention on Psychotropic Substances also classified DMT as a Schedule I drug, indicating that scientific research, medical use, and international trade is meant to be closely monitored; however, because no plants or natural materials containing DMT are controlled under the 1971 Convention on Psychotropic Substance, preparations such as Ayahuasca are not subject to international control, Ayahuasca has been left to religious usage. (Osborn, 2012)

In 1987 the Brazilian government concluded a study on the use of Ayahuasca and declared Ayahuasca legal within the context of religious practice. In 1992, Brazil legalized the possession and use of Ayahuasca from the list of illicit drugs. Through Conselho Federal de Entorpecentes (CONFEN) (Brazil’s Narcotic Federal Council), commission was created to study the ritualistic use of Ayahuasca. (Osborn, 2012)  The assignment was given to a varying group of professionals such as doctors, psychologists, anthropologists, representatives from the Brazilian Justice Ministry, federal police, and army.  The commission conducted tests and interviews throughout varying populations (e.g., Ceu do Mapia village and Rio do Ouro Seringal) and reported:

Excellent social organization, cohesion in the spiritual and personal lives of its members, and superior levels of physical health and education in comparison to others similar settlements in the region (Purus River Valley). In their report, the commission noted an absence of alcoholism and chronic malnutrition; infant mortality and delinquency rates near zero; an absence of violence; and self-respecting habitation, nutrition, and working patterns. These findings led the commission to conclude, in 1987, that “the religious rituals conducted with the sacramental drink Santo Daime/Ahyauasca didn’t bring injuries to the social life, though contributed to its better integration, being remarkable the benefits testified by the usuary, religious groups members” (CONFEN Working group, as cited in “Legalization in Brazil,” 2009, para. 4).

This study cites Brazil as the first country in almost 1600 years to allow plant medicines to be used by non-religious personnel.

Research questions. This inquiry seeks to answer these questions:

  1. Can Ayahuasca be used as a tool to facilitate the healing of addiction and other psychological issues?
  2. Are the patients mental and emotional traumas addressed in the use of plant medicines? (those that caused the addictive behavior initially)
  3. How long will this process take? (How many Ayahuasca ceremonies)
  4. If proper evidence is provided will the United States Government release its ban on plant medicines?
  5. What are the long term effects of Ayahuasca?

Hypothesis: It is hypothesized that legalization of sacred plant medicines such as Ayahuasca once ingested and used in a therapeutic setting with a licensed psychologist, psychiatrist, counselor and or shaman will connect the user to a deeper part of themselves allowing for a transformative experience that will mentally and physically release the person from the grips of addition and other psychological issues.

References

DuPont, R. L. (1979). Marihuana: A review of the issues regarding decriminalization and legalization. In G. M. Beschner &.A. S. Friedman (Eds.), Youth drug abuse: Problems, issues, and treatment (pp. 279-284). Lexington, MA: Lexington Books.

Erowid. (2011). Ayahuasca: Legal status. The vaults ofErowid. Retrieved from http://www.erowid.org/chemicals/ayahuasca/ayahuasca_law.shtml

Inciardi, J. A. (1999). The Drug Legalization Debate. Thousand Oaks: Sage Publications.

Marvin-Humann, K. (2008). The relationship between motivation, Maslow’s hierarchy of needs, time, and craving levels in the mandated substance abuse treatment population (Order No. 3335429). Available from ProQuest Central; ProQuest Dissertations & Theses Full Text. (304835158). Retrieved from http://ezproxy.snhu.edu/login?url=http://search.proquest.com/docview/304835158?accountid=3783

National Institute on Drug Abuse. (2012, December 1). Principles of Drug Addiction Treatment: A Research-Based Guide (Third Edition). Retrieved November 23, 2014, from http://www.drugabuse.gov/publications/principles-drug-addiction-treatment-research-based-guide-third-edition/drug-addiction-treatment-in-united-states

Osborn, S. N. (2012). A phenomenological study of Ayahuasca and its effect on anxiety (Order No. 3537480). Available from ProQuest Dissertations & Theses Full Text. (1321627504). Retrieved from http://ezproxy.snhu.edu/login?url=http://search.proquest.com/docview/1321627504?accountid=3783

Schmoke, K. L. (1989). Foreword. American Behavioral Scientist? 32(3), 231-232

Tupper, K. (2008). The Globalization of Ayahuasca: Harm Reduction or Benefit Maximization? International Journal of Drug Policy, Volume 19(Issue 4), 297-303.

Substance Abuse and Mental Health Services Administration. (SAMHSA) United States Department of Health and Human Services. Office of Applied Studies. National Survey of Substance Abuse Treatment Services (N-SSATS), 2000- 2008. ICPSR03436-v5. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 2014-04-25. http://doi.org/10.3886/ICPSR03436.v5